Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Canellos

Showing results (221-230 of 315) with videos related to

Pageof 32
Sort By:
British Medical Journal|February 9, 1974
Cyclical combination chemotherapy for advanced breast carcinomaG P Canellos, V T Devita, G L Gold, et al.
Blood|June 1, 1976
Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapyG P Canellos, V T DeVita, J Whang-Peng, et al.
Annals of Internal Medicine|April 1, 1976
Combination chemotherapy for advanced breast cancer: response and effect on survivalG P Canellos, V T DeVita, G L Gold, et al.
Lancet (London, England)|July 13, 1974
Letter: Leukaemia and lower-motor-neuron diseaseJ C Costa, A S Rabson, T S Tralka, et al.
Gynecologic Oncology|December 1, 1974
Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideR C Young, G P Canellos, B A Chabner, et al.
Cancer Treatment Reports|January 1, 1981
Treatment of central nervous system tumors with methotrexateH T Abelson, D W Kufe, A T Skarin, et al.
Proceedings. National Cancer Conference|January 1, 1972
Proceedings: Malignant lymphoma: treatment with combination chemotherapyV T De Vita, G P Canellos, P J Schein, et al.
American Journal of Hematology|March 1, 1985
Treatment of the blastic transformation of chronic granulocytic leukemia using high dose BCNU chemotherapy and cryopreserved autologous peripheral blood stem cellsD D Karp, L M Parker, N Binder, et al.
Cancer|August 28, 2003
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicityJonathan W Friedberg, Donna Neuberg, Helen Kim, et al.
Annals of Surgery|January 1, 1987
Splenic enlargement and hyperfunction as indications for splenectomy in chronic leukemiaS J Mentzer, R T Osteen, H F Starnes, et al.
Pageof 32

Showing results (221-230 of 315) with videos related to

Sort By:
Pageof 32
British Medical Journal|February 9, 1974
Cyclical combination chemotherapy for advanced breast carcinomaG P Canellos, V T Devita, G L Gold, et al.
Blood|June 1, 1976
Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapyG P Canellos, V T DeVita, J Whang-Peng, et al.
Annals of Internal Medicine|April 1, 1976
Combination chemotherapy for advanced breast cancer: response and effect on survivalG P Canellos, V T DeVita, G L Gold, et al.
Lancet (London, England)|July 13, 1974
Letter: Leukaemia and lower-motor-neuron diseaseJ C Costa, A S Rabson, T S Tralka, et al.
Gynecologic Oncology|December 1, 1974
Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideR C Young, G P Canellos, B A Chabner, et al.
Cancer Treatment Reports|January 1, 1981
Treatment of central nervous system tumors with methotrexateH T Abelson, D W Kufe, A T Skarin, et al.
Proceedings. National Cancer Conference|January 1, 1972
Proceedings: Malignant lymphoma: treatment with combination chemotherapyV T De Vita, G P Canellos, P J Schein, et al.
American Journal of Hematology|March 1, 1985
Treatment of the blastic transformation of chronic granulocytic leukemia using high dose BCNU chemotherapy and cryopreserved autologous peripheral blood stem cellsD D Karp, L M Parker, N Binder, et al.
Cancer|August 28, 2003
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicityJonathan W Friedberg, Donna Neuberg, Helen Kim, et al.
Annals of Surgery|January 1, 1987
Splenic enlargement and hyperfunction as indications for splenectomy in chronic leukemiaS J Mentzer, R T Osteen, H F Starnes, et al.
Pageof 32